Medicare Will Pay for Prostate Cancer Drug – New York Times (blog)




Forbes (blog)
Medicare Will Pay for Prostate Cancer Drug
New York Times (blog)
Medicare confirmed on Thursday that it would pay for Provenge, the prostate cancer drug whose $ 93000 price had set off debate about the cost of cancer treatments. The Centers for Medicare & Medicaid Services said in a final decision
Medicare confirms payment for prostate cancer drugThe Associated Press
Dendreon Wins Final Medicare Coverage Decision on Prostate Cancer DrugBloomberg
FDA Clears Dendreon 2nd FacilityZacks.com
Xconomy -thestockmasters -Puget Sound Business Journal
all 206 news articles »

DRUG – Google News


Short URL: http://trends-medical.com/?p=314

Posted by on Jun 30 2011. Filed under DRUGS & SUPPLEMENTS. You can follow any responses to this entry through the RSS 2.0. Both comments and pings are currently closed.

Comments are closed

Log in | Medical Trends & News Magazine